TDLAF

 
Common Stock International Reporting
OTCQB
Verified Company Profile 6/17/2016
Contact Info
  • Level 18, 101 Collins Street
  • Melbourne, VIC 3000
  • Australia

Business Description


 
Financial Reporting/Disclosure
Reporting Status International Reporting: ASX - Australian Securities Exchange
Audited Financials Audited
Latest Report Jun 30, 2015 20-F
CIK 0000943502
Fiscal Year End 6/30
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2833 - Medicinal and botanicals
Incorporated In: Australia
Year of Inc. 1989
Employees Not Available
Company Officers/Contacts
Blair Lucas IR
Company Directors
Jitto Arulampalam Chairman
Hongjen Chang
Christopher Harvey
Company Notes
  • Formerly=Progen Pharmaceuticals Ltd. until 11-2016
  • Formerly=Progen Industries Ltd. until 5-07
Service Providers
Accounting/Auditing Firm
BDO Audit
38 Station St
Adelaide, VIC, 5000
Australia

Legal Counsel
Fleur Lankesheer
2806 Ipswich Road,
Darra, Brisbane, QL, 4076
Australia

Investor Relations Firm
Not Available
TDLAF Security Details
Share Structure
Market Value1 $9,122,077 a/o Dec 01, 2016
Authorized Shares 60,545,131 a/o Dec 16, 2014
Outstanding Shares 55,285,315 a/o Dec 16, 2014
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value No Par Value
Shareholders
Shareholders of Record 5 a/o Dec 27, 2010
Non US Stock Exchange Listing
TDL - ASX - Australian Securities Exchange - Qualified
Short Selling Data
Short Interest 0 (-100%)
Sep 30, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security